Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
Delta-Fly Pharma, Inc.
Delta-Fly Pharma, Inc.
Sanofi
Cornerstone Pharmaceuticals
University of Florida
Emory University
Medical College of Wisconsin
Therapeutic Advances in Childhood Leukemia Consortium
Dana-Farber Cancer Institute
Stanford University
University of Pittsburgh
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
University of Pittsburgh
National Cancer Institute (NCI)
Washington University School of Medicine
Texas Oncology Cancer Center
OHSU Knight Cancer Institute